iAnthus Capital Holdings, Inc. in brief
iAnthus Capital Holdings, Inc. is a listed company in the Pharmaceutical industry, based in Vancouver, Canada. It was founded in 2013. Its last known market value was $195 M (January 2024); there is no current figure. In the year to December 2025 it had sales of $144 M and a net loss of $40 M. Its largest product and service lines by sales in 2025 were iAnthus branded products (44%), Third party branded products (38%) and Wholesale/bulk/other products (18%).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
iAnthus Capital Holdings, Inc. timeline
- 2013
- 🏁· approximateFounded
Events of iAnthus Capital Holdings, Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in Canada: #388 (Jan 2020) · #603 (Jan 2021) · #1,140 (Jan 2022) · #467 (Jan 2024)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin (TTM)
- -39.3%
- Operating margin
- -10.7%
- Return on equity
- —
- Liabilities / assets
- 140.3%
- Net debt
- $182M
- Revenue growth
- -14.1%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $144M | -14.1% | $-15M | $-40M | -27.9% |
| Dec 2024 | $168M | +5.2% | $-9M | $-8M | -4.6% |
| Dec 2023 | $159M | -2.4% | $-30M | $-77M | -48.1% |
| Dec 2022 | $163M | -19.6% | $-112M | $-449M | -275.3% |
| Dec 2021 | $203M | +33.9% | $-24M | $-77M | -38.2% |
| Dec 2020 | $152M | — | $-250M | $-313M | -206.6% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $3M | $24M | $-21M | $-0.01 | — |
| Dec 2024 | $13M | $6M | $7M | $0.00 | — |
| Dec 2023 | $4M | $4M | $0M | $-0.01 | — |
| Dec 2022 | $-20M | $7M | $-26M | $-0.13 | — |
| Dec 2021 | $16M | $19M | $-3M | $-0.45 | — |
| Dec 2020 | $-10M | $13M | $-23M | $-1.83 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $38M (+8.4% on a year earlier), net income $-13M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 12, 20268-KCurrent reportResults of operations · Auditor change · Other events
- Nov 12, 202610-QQuarterly report · period to Sep 2026
- Aug 12, 202610-QQuarterly report · period to Jun 2026
- Aug 12, 20268-KCurrent reportResults of operations · Other events
- Jul 1, 20268-KCurrent reportShareholder vote · Other events
- May 19, 2026DEF 14AProxy statement
- May 12, 20268-KCurrent reportResults of operations
- May 12, 202610-QQuarterly report · period to Mar 2026
- May 5, 20268-KCurrent reportDirectors or officers changed · Regulation FD disclosure
- Mar 27, 20268-KCurrent reportResults of operations
- Mar 27, 202610-KAnnual report · period to Dec 2025
- Feb 19, 20268-KCurrent reportOther events
Official filings of iAnthus Capital Holdings, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $144 M
- Operating income
- $-15 M
- Net income
- $-40 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $256 M
- Total liabilities
- $359 M
- Total equity
- $-103 M
As of December-2025
Insider trading at iAnthus Capital Holdings, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Jason Matthew WareCFO | Grant or award | +78.95 M | — | — | 78.95 M | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
iAnthus Capital Holdings, Inc. scorecard#
Passes 3 of the 15 checks that could be worked out: strongest in profitability (1 of 4), weakest in growth (1 of 6). Fiscal year 2025.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth1 of 6
- ✗Revenue grew in the newest year-14.1%Revenue down 14.1% in fiscal 2025.
- ✗Revenue up more than 5% a year over three years-4.1%-4.1% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median-4.1%-4.1% a year against Pharmaceutical's median of 2.5% (65 companies).
- ✗Earnings per share grew in the newest year-0.01 vs 0.00Diluted EPS -0.01 in fiscal 2025 against 0.00 the year before (report's currency).
- ✓Net income higher than five years earlier-$40 M-$40 M in fiscal 2025 against -$313 M in 2020.
- ✗Revenue rose in at least four of the last five years2 of 5Revenue rose in 2 of the five years to fiscal 2025.
Profitability1 of 4
- ✗Profitable in the newest year-$40 MNet income -$40 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-10.7%-10.7% against Pharmaceutical's median of 1.8% (74 companies).
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier-10.7%-10.7% in fiscal 2025 against -68.9% in 2022.
Financial health1 of 4
- ✗Short-term assets cover short-term liabilities0.7×Current ratio 0.71 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- ✗Net debt below three years of EBITDA47.1×Net debt 47.1 times EBITDA in fiscal 2025.
- ✗Operating income covers interest five times-0.9×Operating income -0.9 times interest in fiscal 2025.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year2.5%Diluted shares up 2.5% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Pharmaceutical, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from iAnthus Capital Holdings, Inc.'s statements, beside the median of Pharmaceutical.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -10.7% | 1.8% | |
| Net margin | -27.9% | -1.5% | |
| Revenue growth, 3 years a year | -4.1% | 2.5% | |
| Revenue growth | -14.1% | 7.3% | |
| Free cash flow margin | -14.3% | 6.0% |
3of 9on the Piotroski tests of financial strength
- Revenue fell 14.1% against the year before.
- Net loss of $40 million, the 6th loss-making year in a row.
- Free cash flow was negative: -$21 million.
- Shareholders' equity is negative: -$103 million.
iAnthus Capital Holdings, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 144−14.1%100% | 168+5.2%100% | 159−2.4%100% | 163−19.6%100% | 203+33.9%100% | 152—100% | |
| Cost of revenue | 78−15.3%54.4% | 92−3.8%55.2% | 96+8.2%60.3% | 89−5.0%54.4% | 93r92+33.9%46.1% | 70—46.0% | |
| Gross profit | 66−12.5%45.6% | 75+18.9%44.8% | 63−15.1%39.7% | 74−32.0%45.6% | 110r111+33.8%53.9% | 82—54.0% | |
| Selling, general and administrative | 61−2.1%42.3% | 62−8.4%37.1% | 68r78−47.0%42.6% | 128+32.1%78.5% | 97−1.4%47.8% | 98—64.9% | |
| Operating expenses | 81−3.0%56.3% | 84−10.0%49.9% | 93r104−50.3%58.3% | 187+40.2%115% | 133−59.8%65.7% | 332—219% | |
| Total costs and expenses | — | — | — | 0−100%0.0% | 1.9—0.9% | 0—0.0% | |
| Operating income | −15—−10.7% | −8.5—−5.1% | −30r−41—−18.7% | −112—−68.9% | −24r−22—−11.7% | −250—−165% | |
| Interest and finance income | — | — | — | 0.1−83.4%0.1% | 0.5+28.3%0.3% | 0.4—0.3% | |
| Interest expense and finance costs | 17−3.3%11.5% | 17+9.1%10.2% | 16−15.6%9.9% | 19r0.8+998%11.4% | 1.7−50.0%0.8% | 3.4—2.2% | |
| Share of profit of associates | −0.0—−0.0% | −0.2—−0.1% | −0.2—−0.1% | 0—0.0% | 0−100%0.0% | 0.2—0.1% | |
| Income before tax | −23—−16.1% | −25—−15.1% | −49r−60—−31.1% | −439—−269% | −56r−54—−27.5% | −295—−194% | |
| Income tax | 17—11.8% | −18−165%−10.5% | 27r17+154%17.1% | 11−50.8%6.6% | 22r22+16.7%10.7% | 19—12.3% | |
| Net income including minority interests | — | — | 77—48.1% | — | — | — | |
| Net income attributable to shareholders | −40—−27.9% | −7.6—−4.6% | −77—−48.1% | −449—−275% | −77r−76—−38.2% | −313—−207% | |
| Earnings per share, basic | -0.01—— | 0.00—— | -0.01—— | -0.13—— | -0.45r-0.44—— | -1.83—— | |
| Earnings per share, diluted | -0.01—— | 0.00—— | -0.01—— | -0.13—— | -0.45r-0.44—— | -1.83—— | |
| Shares, weighted average (basic) | 6,702+2.5%— | 6,540+1.6%— | 6,437r6.4+190835%— | 3.4+1863%— | 0.2—— | — | |
| Shares, weighted average (diluted) | 6,702+2.5%— | 6,540+1.6%— | 6,437r6.4+190835%— | 3.4+1863%— | 0.2r172−99.9%— | 172—— | |
| Balance sheet | |||||||
| Cash and cash equivalents | 12−37.2%4.6% | 19+41.5%6.8% | 13−8.6%4.7% | 14+8.2%4.7% | 13+20.2%3.8% | 11—3.1% | |
| Receivables | 6.4+16.1%2.5% | 5.5+20.1%2.0% | 4.6+15.3%1.7% | 4.0+11.2%1.3% | 3.6+7.3%1.0% | 3.4—0.9% | |
| Inventory | 22−1.0%8.7% | 22−11.5%8.3% | 25−14.8%9.1% | 30+3.9%9.8% | 29r30+12.7%8.3% | 25—7.2% | |
| Other current assets | 4.6+183%1.8% | 1.6+576%0.6% | 0.2+20.3%0.1% | 0.2−87.4%0.1% | 1.6−5.7%0.5% | 1.7—0.5% | |
| Current assets | 49−34.7%19.0% | 75+64.0%27.5% | 46−10.1%16.4% | 51−5.6%16.7% | 54r55+17.6%15.6% | 46—12.9% | |
| Property, plant and equipment | 105+19.7%40.9% | 87−6.9%32.3% | 94−9.0%33.9% | 103−8.3%34.0% | 113+5.3%32.6% | 107—30.3% | |
| Right-of-use (leased) assets | 29+22.6%11.5% | 24−12.3%8.9% | 27−3.6%9.9% | 28−6.7%9.4% | 30−8.0%8.8% | 33—9.4% | |
| Goodwill | 1.6−74.7%0.6% | 6.1—2.3% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | |
| Other intangible assets | 67−7.4%26.4% | 73−30.9%26.9% | 105−10.0%38.0% | 117−15.8%38.6% | 139−12.4%40.3% | 159—45.0% | |
| Long-term investments | 0.8−2.4%0.3% | 0.9+17.4%0.3% | 0.7+217%0.3% | 0.2−59.2%0.1% | 0.6+10.9%0.2% | 0.5—0.1% | |
| Total assets | 256−5.6%100% | 271−2.3%100% | 277−8.6%100% | 303−12.0%100% | 345r347−2.3%100% | 353—100% | |
| Accounts payable | 16+26.8%6.4% | 13−10.9%4.7% | 14+34.7%5.2% | 11−21.6%3.5% | 14+12.8%4.0% | 12—3.4% | |
| Debt due within a year | 0−100%0.0% | 0.1+18.2%0.0% | 0.1+7.8%0.0% | 0.1−100.0%0.0% | 165+5.3%47.9% | 157—44.5% | |
| Current liabilities | 69−9.0%26.8% | 75−40.0%27.8% | 125+35.5%45.2% | 93−67.6%30.5% | 285r286+23.0%82.7% | 232—65.7% | |
| Long-term debt | 194+6.4%75.8% | 182+10.3%67.2% | 165+12.2%59.6% | 147+426%48.5% | 28+98.1%8.1% | 14—4.0% | |
| Lease liabilities (non-current) | 27+24.0%10.5% | 22−22.9%8.0% | 28−2.9%10.1% | 29+3.7%9.5% | 28+0.5%8.1% | 28—7.8% | |
| Total liabilities | 359+6.7%140% | 337−0.7%124% | 339+15.9%122% | 292−20.7%96.4% | 369r369+20.5%107% | 306—86.6% | |
| Retained earnings | −1,375—−537% | −1,335—−493% | −1,328—−479% | −1,251—−412% | −802r−800—−232% | −724—−205% | |
| Shareholders' equity | −103—−40.3% | −66—−24.2% | −62−661%−22.2% | 11—3.6% | −24r−22−150%−6.9% | 47—13.4% | |
| Total liabilities and equity | 256−5.6%100% | 271−2.3%100% | 277−8.6%100% | 303−12.0%100% | 345r347−2.3%100% | 353—100% | |
| Shares outstanding | 6,859+2.7%— | 6,678+2.6%— | 6,511r6.5+101575%— | 6.4r172−96.3%— | 1720.0%— | 172—— | |
| Cash-flow statement | |||||||
| Depreciation and amortization | 19−22.0%13.4% | 25−9.0%14.8% | 27−13.4%17.1% | 31+1.1%19.2% | 31+11.2%15.3% | 28—18.4% | |
| Share-based compensation | 1.8−12.4%1.3% | 2.1−53.5%1.3% | 4.5−85.1%2.8% | 30+367%18.6% | 6.5−43.5%3.2% | 12—7.6% | |
| Cash from operating activities | 3.1−74.9%2.2% | 13+232%7.5% | 3.8r3.0—2.4% | −19−221%−11.9% | 16—8.0% | −9.8—−6.5% | |
| Capital expenditure | −24—−16.5% | −5.5—−3.3% | −3.6—−2.2% | −6.9—−4.3% | −19—−9.6% | −13—−8.9% | |
| Intangible assets bought | −0.1—−0.1% | −0.2—−0.1% | −2.5—−1.6% | −0.1—−0.1% | −1.0—−0.5% | −0.8—−0.5% | |
| Cash from investing activities | 2.3—1.6% | −6.3—−3.7% | −4.4r−3.6—−2.8% | −4.7—−2.9% | −21—−10.5% | −15—−9.7% | |
| Debt issued | — | — | 0−100%0.0% | 24+120%14.9% | 11−25.4%5.4% | 15—9.7% | |
| Debt repaid | −7.4—−5.1% | −0.1—−0.0% | −0.0—−0.0% | −0.4—−0.2% | −0.1—−0.0% | −11—−7.4% | |
| Cash from financing activities | −13—−8.8% | −0.3—−0.2% | −0.6−103%−0.4% | 22+116%13.5% | 10+714%5.0% | 1.3—0.8% | |
| Change in cash | −7.2−222%−5.0% | 5.9—3.5% | −1.2—−0.8% | −2.2−143%−1.3% | 5.1—2.5% | −23—−15.4% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 143−5.9%100% | 38+8.4%100% | 35+0.5%100% | 34−12.1%100% | 35*−17.4%100% | 35−12.2%100% | 35−18.2%100% | 38−8.3%100% | 43*+4.5%100% | 40—100% | 43—100% | 42—100% | 41*—100% | |
| Cost of revenue | 79−3.6%55.3% | 22+9.5%56.5% | 19+1.1%54.5% | 18−8.6%52.5% | 20*−14.3%57.3% | 20−10.8%56.0% | 19−14.7%54.1% | 19−21.0%50.5% | 24*−5.5%55.2% | 22—55.1% | 22—51.9% | 24—58.6% | 25*—61.1% | |
| Gross profit | 64−8.6%44.7% | 17+7.0%43.5% | 16−0.3%45.5% | 16−15.7%47.5% | 15*−21.2%42.7% | 16−13.8%44.0% | 16−21.9%45.9% | 19+9.7%49.5% | 19*+20.2%44.8% | 18—44.9% | 21—48.1% | 17—41.4% | 16*—38.9% | |
| Selling, general and administrative | 54−14.5%38.0% | 13−12.8%34.2% | 14−14.2%38.4% | 14−14.9%42.7% | 13*−16.0%37.5% | 15−3.9%42.5% | 16+6.1%44.9% | 17+5.9%44.1% | 16*−3.2%36.9% | 16—38.8% | 15—34.7% | 16r18—38.2% | 16r19*—39.8% | |
| Operating expenses | 74−11.6%51.8% | 18−7.7%47.7% | 18−14.6%52.0% | 18−12.8%54.3% | 19*−11.0%53.5% | 20+2.5%56.0% | 22+2.9%61.2% | 21−5.8%54.8% | 21*−5.6%49.6% | 19—48.0% | 21—48.6% | 22r24—53.3% | 22r26*—55.0% | |
| Operating income | −10.0—−7.0% | −1.6—−4.2% | −2.3—−6.4% | −2.3—−6.8% | −3.8*—−10.7% | −4.2—−12.0% | −5.4—−15.3% | −2.0—−5.3% | −2.1*—−4.8% | −1.3—−3.1% | −0.2—−0.5% | −5.0r−6.6—−11.9% | −6.5r−9.6*—−16.0% | |
| Interest expense and finance costs | 17+0.8%11.9% | 4.4+6.3%11.5% | 4.3+4.7%12.1% | 4.1−1.6%12.4% | 4.2*−5.7%11.8% | 4.1−4.8%11.7% | 4.1−4.0%11.6% | 4.2+1.4%11.0% | 4.4*+8.1%10.4% | 4.4—10.8% | 4.2—9.9% | 4.2—10.0% | 4.1r16*—10.0% | |
| Share of profit of associates | 0.2—0.1% | 0.1*+667%0.2% | 0.1*+1180%0.2% | 0.0—0.1% | −0.0*—−0.0% | 0.0*—0.0% | 0.0*—0.0% | −0.0—−0.0% | −0.0*—−0.1% | −0.0*—−0.1% | −0.1*—−0.1% | −0.1—−0.1% | −0.2*—−0.4% | |
| Income before tax | −30—−20.7% | −6.2—−16.1% | −7.4—−20.9% | −7.3−180%−21.8% | −8.7*—−24.6% | −9.1—−25.6% | −15—−41.5% | 9.2—24.0% | −6.8*—−15.9% | −6.0—−14.9% | −2.9—−6.7% | −9.6r−11—−23.2% | −11r−15*—−28.1% | |
| Income tax | 26—18.6% | 7.0+102%18.3% | 7.0+70.2%19.9% | 7.0+74.5%20.9% | 5.4*—15.4% | 3.5−38.5%9.8% | 4.1−40.3%11.7% | 4.0−8.0%10.5% | −35*−579%−81.0% | 5.6—14.0% | 6.9—16.1% | 4.4r2.7—10.5% | 7.2r4.1*—17.7% | |
| Net income attributable to shareholders | −56−3435%−39.3% | −13—−34.4% | −14—−40.8% | −14−378%−42.7% | −14*−151%−39.9% | −13—−35.4% | −19—−53.2% | 5.2—13.5% | 28*—65.1% | −12—−28.9% | −9.8—−22.8% | −14—−33.7% | −19*—−45.7% | |
| Earnings per share, basic | — | 0.00—— | 0.00—— | 0.00—— | — | 0.00—— | 0.00—— | 0.00—— | — | 0.00—— | 0.00—— | 0.00—— | — | |
| Earnings per share, diluted | — | 0.00—— | 0.00—— | 0.00—— | — | 0.00—— | 0.00—— | 0.00—— | — | 0.00—— | 0.00—— | 0.00—— | — | |
| Shares, weighted average (basic) | 6,967+3.2%— | 6,967+3.2%— | 6,965+3.2%— | 6,965+3.4%— | — | 6,753+3.6%— | 6,748+3.6%— | 6,738+2.5%— | — | 6,522—— | 6,511r6.5—— | 6,574r6.6—— | — | |
| Shares, weighted average (diluted) | 6,967+3.2%— | 6,967+3.2%— | 6,965+3.2%— | 6,965+3.4%— | — | 6,753+3.6%— | 6,748+3.6%— | 6,738+2.5%— | — | 6,522—— | 6,511r6.5—— | 6,574r6.6—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 6.6—2.6% | 6.6−61.5%2.6% | 8.0−65.7%3.1% | 11−54.1%4.4% | 12−37.2%4.6% | 17−13.7%6.7% | 23+41.8%8.7% | 24+78.0%8.9% | 19+41.5%6.8% | 20—7.4% | 17—6.1% | 14—5.0% | 13—4.7% | |
| Receivables | 6.6—2.6% | 6.6+23.1%2.6% | 5.5+15.6%2.1% | 6.8−32.2%2.6% | 6.4+16.1%2.5% | 5.3+0.3%2.1% | 4.7−27.8%1.8% | 10.0+51.9%3.7% | 5.5+20.1%2.0% | 5.3—2.0% | 6.6—2.4% | 6.6—2.4% | 4.6—1.7% | |
| Inventory | 29—11.1% | 29+35.5%11.1% | 26+20.1%10.1% | 25+27.1%9.6% | 22−1.0%8.7% | 21−10.3%8.3% | 22−14.2%8.1% | 19−22.0%7.1% | 22−11.5%8.3% | 24—8.7% | 25—9.3% | 25—9.0% | 25—9.1% | |
| Other current assets | 2.6—1.0% | 2.6−39.5%1.0% | 3.8−27.9%1.5% | 4.2−18.4%1.7% | 4.6+183%1.8% | 4.3+132%1.7% | 5.2+198%1.9% | 5.2+241%1.9% | 1.6+576%0.6% | 1.9—0.7% | 1.8—0.6% | 1.5—0.6% | 0.2—0.1% | |
| Current assets | 50—19.2% | 50−6.2%19.2% | 46−20.0%18.0% | 50−20.7%19.5% | 49−34.7%19.0% | 53−3.4%20.6% | 58+10.7%21.6% | 63+28.2%23.1% | 75+64.0%27.5% | 55—20.1% | 52—19.2% | 49—18.0% | 46—16.4% | |
| Property, plant and equipment | 112—43.4% | 112+12.9%43.4% | 113+22.1%43.7% | 106+17.5%41.5% | 105+19.7%40.9% | 99+10.3%38.7% | 92+1.7%34.4% | 90−1.9%33.2% | 87−6.9%32.3% | 90—33.1% | 91—33.3% | 92—33.7% | 94—33.9% | |
| Right-of-use (leased) assets | 31—11.8% | 31+11.1%11.8% | 31+10.8%12.0% | 29+15.4%11.3% | 29+22.6%11.5% | 27+4.8%10.7% | 28+9.4%10.4% | 250.0%9.2% | 24−12.3%8.9% | 26—9.7% | 26—9.4% | 25r25—9.1% | 27—9.9% | |
| Goodwill | 1.6—0.6% | 1.6−76.6%0.6% | 1.6−76.0%0.6% | 1.6−75.3%0.6% | 1.6−74.7%0.6% | 6.7—2.6% | 6.5—2.4% | 6.3—2.3% | 6.1—2.3% | — | — | — | 0—0.0% | |
| Other intangible assets | — | — | — | — | 67−7.4%26.4% | — | — | — | 73−30.9%26.9% | — | — | — | 105—38.0% | |
| Long-term investments | 1.0—0.4% | 1.0+18.7%0.4% | 0.9+11.7%0.4% | 0.9+4.3%0.3% | 0.8−2.4%0.3% | 0.9−1.5%0.3% | 0.8−8.8%0.3% | 0.8−3.9%0.3% | 0.9+17.4%0.3% | 0.9—0.3% | 0.9—0.3% | 0.9—0.3% | 0.7—0.3% | |
| Total assets | 258—100% | 258+0.7%100% | 258−3.8%100% | 256−6.1%100% | 256−5.6%100% | 256−5.6%100% | 269−1.4%100% | 273−0.5%100% | 271−2.3%100% | 271—100% | 272—100% | 274—100% | 277—100% | |
| Accounts payable | 17—6.8% | 17+71.4%6.8% | 16+9.5%6.1% | 17+48.7%6.5% | 16+26.8%6.4% | 10−29.3%4.0% | 14−6.0%5.4% | 11−22.2%4.1% | 13−10.9%4.7% | 14—5.3% | 15—5.7% | 14—5.3% | 14—5.2% | |
| Debt due within a year | 224—87.1% | 224+2557%87.1% | 204+1716%78.8% | — | 0−100%0.0% | 8.4+13748%3.3% | 11+18902%4.2% | 12+21538%4.4% | 0.1+18.2%0.0% | 0.1—0.0% | 0.1—0.0% | 0.1—0.0% | 0.1—0.0% | |
| Current liabilities | 287—111% | 287+306%111% | 279+253%108% | 72−7.6%28.1% | 69−9.0%26.8% | 71−18.0%27.6% | 79−33.7%29.5% | 78−39.5%28.6% | 75−40.0%27.8% | 86—31.7% | 119—43.9% | 129—47.0% | 125—45.2% | |
| Long-term debt | 0—0.0% | 0−100%0.0% | 0−100%0.0% | 199+16.1%77.7% | 194+6.4%75.8% | 181+1.8%70.6% | 176+1.7%65.5% | 171+1.7%62.8% | 182+10.3%67.2% | 178—65.5% | 173—63.5% | 168—61.5% | 165—59.6% | |
| Lease liabilities (non-current) | 28—10.8% | 28+13.4%10.8% | 28+13.0%10.9% | 26+17.7%10.3% | 27+24.0%10.5% | 25+4.8%9.6% | 25+4.5%9.3% | 220.0%8.2% | 22−22.9%8.0% | 23—8.7% | 24—8.8% | 22r27—8.2% | 28—10.1% | |
| Total liabilities | 401—156% | 401+16.1%156% | 389+12.3%151% | 373+12.2%146% | 359+6.7%140% | 346−5.3%135% | 347−2.3%129% | 332−4.3%122% | 337−0.7%124% | 365—135% | 355—130% | 347—127% | 339—122% | |
| Retained earnings | −1,417—−550% | −1,417—−550% | −1,404—−543% | −1,390—−543% | −1,375—−537% | −1,361—−532% | −1,349—−502% | −1,330—−488% | −1,335—−493% | −1,363—−503% | −1,351—−496% | −1,330r−1,342—−486% | −1,328—−479% | |
| Shareholders' equity | −144—−55.7% | −144—−55.7% | −131—−50.6% | −117—−45.7% | −103—−40.3% | −90—−35.0% | −78—−29.0% | −60—−21.9% | −66—−24.2% | −94—−34.5% | −82—−30.3% | −73—−26.8% | −62—−22.2% | |
| Total liabilities and equity | 258—100% | 258+0.7%100% | 258−3.8%100% | 256−6.1%100% | 256−5.6%100% | 256−5.6%100% | 269−1.4%100% | 273−0.5%100% | 271−2.3%100% | 271—100% | 272—100% | 274—100% | 277—100% | |
| Shares outstanding | 6,975—— | 6,975+2.3%— | 6,973+3.5%— | 6,973+3.4%— | 6,859+2.7%— | 6,817+2.9%— | 6,736+1.8%— | 6,746+2.0%— | 6,678+2.6%— | 6,627—— | 6,615—— | 6,615—— | 6,511r6.5—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 20+1.3%14.2% | 5.5*+19.2%14.4% | 4.7*+2.3%13.3% | 4.7−0.7%13.9% | 5.3*−11.6%15.1% | 4.6*−17.4%13.1% | 4.6*−19.4%13.1% | 4.7−26.1%12.4% | 6.0*−10.7%14.2% | 5.6—13.9% | 5.7—13.3% | 6.4—15.3% | 6.8*—16.6% | |
| Share-based compensation | 1.8−7.9%1.3% | 0.4*−4.2%1.1% | 0.5*−4.0%1.5% | 0.5−3.3%1.5% | 0.3*−22.7%0.9% | 0.5*−13.5%1.3% | 0.5*−25.1%1.5% | 0.5+20.0%1.4% | 0.4*−56.8%1.0% | 0.5*—1.3% | 0.7*—1.7% | 0.4—1.0% | 1.0*—2.4% | |
| Cash from operating activities | 3.5+15.5%2.5% | −0.2*—−0.6% | 0.8*−75.9%2.2% | 1.0−67.5%3.0% | 2.0*+5.9%5.6% | −5.1*−206%−14.4% | 3.2*−27.9%9.0% | 3.1+107%8.2% | 1.9*—4.3% | 4.8*—11.9% | 4.4*—10.2% | 1.5—3.6% | −1.0r−1.7*—−2.5% | |
| Capital expenditure | −15—−10.5% | −2.3*—−6.1% | −3.6*—−10.2% | −2.0—−6.1% | −7.0*—−19.9% | −8.4*—−23.7% | −3.6*—−10.3% | −4.8—−12.5% | −2.8*—−6.4% | −1.1*—−2.7% | −0.8*—−1.8% | −0.9—−2.1% | −1.1*—−2.7% | |
| Intangible assets bought | −0.2—−0.2% | −0.1—−0.2% | −0.1—−0.2% | −0.0—−0.1% | −0.1*—−0.2% | −0.0—−0.0% | −0.1—−0.1% | −0.1—−0.3% | — | −0.2—−0.4% | −0.0—−0.1% | −0.0—−0.0% | −0.1*—−0.2% | |
| Cash from investing activities | −14−312%−9.5% | −1.0*−147%−2.5% | −3.4*—−9.7% | −1.6−115%−4.8% | −7.6*—−21.5% | 2.1*—5.8% | −3.3*—−9.4% | 11—29.1% | −3.5*—−8.1% | −0.8*—−1.9% | −1.2*—−2.7% | −0.9—−2.2% | −0.1r0.1*—−0.3% | |
| Debt issued | — | — | — | — | — | — | — | — | — | — | — | — | 0*—0.0% | |
| Debt repaid | −0.7—−0.5% | −0.1*—−0.2% | −0.3*—−0.7% | −0.1—−0.2% | −0.3*—−0.8% | −3.0*—−8.3% | −0.9*—−2.5% | −3.3—−8.5% | −0.0*—−0.0% | −0.0*—−0.0% | −0.0*—−0.0% | −0.0—−0.0% | −0.0*—−0.0% | |
| Cash from financing activities | −1.0—−0.7% | −0.3*—−0.7% | −0.3*—−0.7% | −0.1—−0.2% | −0.5*—−1.3% | −3.0*—−8.4% | −1.0*—−2.8% | −8.3—−21.7% | −0.2*—−0.4% | −0.1*—−0.3% | −0.0*—−0.0% | −0.1—−0.1% | −0.3*—−0.8% | |
| Change in cash | −11—−7.8% | −1.5*—−3.8% | −2.9*—−8.3% | −0.7−111%−2.0% | −6.1*—−17.2% | −6.0*−253%−17.0% | −1.1*−135%−3.2% | 6.0+978%15.6% | −1.8*—−4.1% | 3.9*—9.7% | 3.2*—7.5% | 0.6—1.3% | −1.5r−2.0*—−3.6% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What iAnthus Capital Holdings, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- iAnthus branded products$63 M44%-26%
- Third party branded products$55 M38%-15%
- Wholesale/bulk/other products$26 M18%+41%
Business segments
- Eastern Region$134 M93%+3.9%
- Western Region$10 M7.2%-73%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Where iAnthus Capital Holdings, Inc. operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 1 subsidiaries on file.
| Country | Presence | Revenue there |
|---|---|---|
| 🇨🇦 Canada | Headquarters | — |
| 🇱🇺 Luxembourg | 1 subsidiary | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Events at iAnthus Capital Holdings, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Financial statements withdrawn 1 · Auditor changed 1 · Acquisition or sale completed 1 · Directors and officers 4 · Material agreement 1 · Shareholder vote 3 · Results announced 11
| Filed | What happened | Filing |
|---|---|---|
| Auditor changedResults announced | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Acquisition or sale completed | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Financial statements withdrawn | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026
Acquisitions and funding#
1 acquisitions, $6 M paid where reported · 5 private funding rounds before listing
Businesses it acquired
| Acquired | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|
| Cheetah Enterprises, Inc | 2025 | — | $6 M | — | Annual report |
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Mar 2019 | $27 M | No. 5 | $10 to $50 million | 3 | debt, options | SEC |
| May 2018 | $40 M | No. 4 | $10 to $50 million | 2 | debt, options | SEC |
| Apr 2018 | $4 M | Issued in a merger or acquisition | $2 to $10 million | 8 | equity | SEC |
| Feb 2018 | $13 M | Issued in a merger or acquisition | $10 to $50 million | 57 | equity | SEC |
| Jan 2018 | $20 M | No. 3 | $10 to $50 million | 1 | debt, options | SEC |
| Nov 2017 | $2 M | No. 2 | $2 to $10 million | 20 | equity | SEC |
| Nov 2016 | $1 M | No. 1 | Under $2 million | 27 | equity, options | SEC |
| Aug 2016 | $9 M | Issued in a merger or acquisition | $2 to $10 million | 8 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
How iAnthus Capital Holdings, Inc. compares in Pharmaceutical
- Revenue$144 M · higher than 24% of 324
- Net margin-39.3% · higher than 8% of 313
- Revenue growth-14.1% · higher than 10% of 107
- 🇺🇸 Athenex$144 M
- 🇮🇳 Shilpa Medicare Limited$1.9 B
- 🇨🇦 Cronos Group Inc$1.2 B
- 🇰🇷 Yungjin Pharm. Co., Ltd.$172 M
- 🇮🇹 Pharmanutra S.p.A.$148 M
- 🇺🇸 Elite Pharmaceuticals, Inc.$149 M
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| iAnthus Capital Holdings, Inc.🇨🇦 | $195 M | — | -39.3% | -14.1% |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- Merck & Co., Inc.$359.8 B
- Novartis AG$286.8 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 16, 2026
Figures from SEC filing, value.today research; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at iAnthus Capital Holdings, Inc.? Verify and update this profile — free
Show iAnthus Capital Holdings, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.